Contact Information: CONTACT: Michael Brennan Chairman Email: Telephone: (805) 557-0614
MIT Successfully Completes Rigorous Performance Tests
| Source: Micro Imaging Technology, Inc.
SAN CLEMENTE, CA--(Marketwire - December 17, 2007) - Micro Imaging Technology, Inc. (OTCBB : MMTC ) announces the successful completion of rigorous microorganism
identification accuracy testing. The Company tested three MIT Rapid
Microbial ID Systems for identification accuracy on a total of eight
different species' strains of E.coli, Staphylococcus aureus and Salmonella.
The MIT 1000 System produces results in less than ten minutes after
completion of the culturing process without using chemicals, reagents or
DNA processing.
The objectives of the test were twofold. The first objective was to
determine the System's ability to accurately identify specific bacterial
species strains that were programmed into the System's database. The
second objective was to determine the System's robustness to accurately
identify the correct species when presented with a strain of that species
not programmed into the System's database. The organisms were chosen based
on customer interest and frequency of reported contamination cases found in
food processing, food products, hospitals, and other public environments.
Of the 151 tests performed, 40% were tested with the actual species strain.
The remaining tests provided accuracy performance of specific species
strains not in the System's database. The results showed that the three
systems achieved 100% identification accuracy for all species when the
specific strain was programmed into the Product's database and 91% accuracy
for all testing conducted.
MIT's CTO Dr. David Haavig stated, "The perfect results achieved for those
species strains within our database met our expectations and we are pleased
to see the robust performance of the MIT 1000 System when presented with a
species strain not contained in the database. This will enable our
customers to confidently use our System with a wide variety of organisms
and obtain consistent and reliable identification results. This
performance also suggests that minor adjustments to our algorithms may
improve the performance to obtain near 100% accuracy for all strains of a
species."
About Micro Imaging Technology
The Company has developed and patented a technology for rapid microbe
detection and identification. This System measures scattered light
intensity as individual microbes pass through a laser beam. The intensity
pattern of the scattered light is a direct consequence of the size, shape
and external and internal optical characteristics of the microbe. The MIT
System is non-biological and does not rely on biological agents,
conventional chemical processing, fluorescent tags, gas chromatography or
DNA analysis.
MIT has demonstrated the ability to detect and identify, within several
minutes, the microbes Escherichia coli, Listeria, Salmonella,
Staphylococcus aureus, Shigella and other pathogenic bacteria. The
identification process has been verified by North American Science
Associates, Inc. (NAMSA), an independent, internationally recognized
biological testing laboratory. The Test Report, in the Company's opinion,
demonstrated the accuracy, speed and efficiency of the MIT System over
conventional processes and is available from the Company. The MIT 1000
System was recently featured in a Rapid Microbiology international
newsletter and can be viewed at
http://www.rapidmicrobiology.com/news/1231h0.php?s=MIT.
This release contains statements that are forward-looking in nature.
Statements that are predictive in nature, that depend upon or refer to
future events or conditions or that include words such as "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions are forward-looking statements. These statements are made
based upon information available to the Company as of the date of this
release, and we assume no obligation to update any such forward-looking
statements. These statements are not guarantees of future performance and
actual results could differ materially from our current expectations.
Factors that could cause or contribute to such differences include, but are
not limited to dependence on suppliers; short product life cycles and
reductions in unit selling prices; delays in development or shipment of new
products; lack of market acceptance of our new products or services;
inability to continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and other
factors and risks associated with our business are discussed from time to
time within our filings with the Securities and Exchange Commission.